NEUROGENIX XL

DEAD

Serial Number

97031618

Owner

Centinela Medical Center of South Bay Inc.

First Use Date

Jun 11, 2020

Filing Date

Sep 16, 2021

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

NEUROGENIX XL Trademark

Serial Number: 97031618

NEUROGENIX XL is a trademark filed by Centinela Medical Center of South Bay Inc. on September 16, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Centinela Medical Center of South Bay Inc. (6 trademarks)

15901 Hawthorne Blvd STE 450
Lawndale, CA 90260

Entity Type: 03

Legal Representation

Correspondence Address

Centinela Medical Center of South Bay Inc.

15901 Hawthorne Blvd STE 450

Lawndale

CA 90260

UNITED STATES OF AMERICA

Trademark Details

Filing Date

September 16, 2021

Registration Date

Not Registered

First Use Anywhere

June 11, 2020

First Use in Commerce

June 11, 2020

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Oct 26, 2023 MAB2

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND

Oct 26, 2023 MAB2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Oct 26, 2023 ABN2

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jul 12, 2023 GNRN

NON-FINAL ACTION E-MAILED

Jul 12, 2023 GNRT

NON-FINAL ACTION WRITTEN

Jul 12, 2023 CNRT

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

May 31, 2023 RCCK

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Nov 18, 2022 GNS3

LETTER OF SUSPENSION E-MAILED

Nov 18, 2022 GNSL

SUSPENSION LETTER WRITTEN

Nov 18, 2022 CNSL

TEAS/EMAIL CORRESPONDENCE ENTERED

Nov 17, 2022 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 17, 2022 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 17, 2022 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 17, 2022 GNRN

NON-FINAL ACTION E-MAILED

May 17, 2022 GNRT

NON-FINAL ACTION WRITTEN

May 17, 2022 CNRT

ASSIGNED TO EXAMINER

May 6, 2022 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 21, 2021 NWOS

NEW APPLICATION ENTERED

Sep 20, 2021 NWAP

Related Trademarks

More from this Owner

IMMUNOGENIX XL

PROSTAR XL

IMMUNOGENIX XL

ANDROGENIX XL

More in Same Class

NOURISH

PURCANN PHARMA

CFTR MF

CFTR SPECIFIC MODULATOR FORMULATION

CBD LIVE RESIN